Wall Street looks for direction – Crowdstrike opened down 12%

Wall Street’s key stock indexes are looking for direction at Friday’s opening.

After opening, the S&P 500 traded in the previous day’s closing readings, while the Dow Jones slipped 0.5 percent. The technology-focused Nasdaq 100 was up 0.2 percent at the time of the review.

The US cyber security company that was behind the global communication disruption that broke out on Friday Crowdstrike started to decline as expected. Within ten minutes, the company’s price was down 11.9 percent.

In premarket trading on Wall Street, which ends half an hour before the stock market opens, Crowdstrike’s stock ended down 11.7 percent. Earlier on Friday, it was down more than 19 percent during pre-trading.

CEO of Crowdstrike George Kurtz has apologized for the disruptions caused by the company’s update, which hit globally Microsoft’s For users of Windows systems and the Azure cloud service.

Microsoft’s course fluctuated around zero at the opening. At the time of the review, it was down 0.1 percent.

A cyber security company that is one of Crowdstrike’s US competitors Palo Alto Networks was up 1.2 percent. Operating in the same sector Fortinet spin at zero.

According to Bloomberg, thousands of flights were postponed and canceled on Friday in various parts of the United States and Europe, as well as in India. Problems were also reported in the banks’ systems.

The disruption also affected, among other things, the services of the London Stock Exchange. Trading on the Australian stock exchange was extended by half an hour as a result of the exceptional situation.

The problems remained minor in China, where, due to strained geopolitical relations and competition in the technology sectors, efforts have been made to avoid dependence on the services of US technology companies.

Rising in the S&P 500 index were among others the streaming service company that reported strong growth in the number of users Netflix (+4.7%) and a pharmaceutical company Eli Lilly & Co (+2.8 %), whose slimming drug was approved by the authorities in China.